Further evidence linking these hub genes with the development of resistance, was provided by survival analysis which revealed that out of the 10 upregulated hub genes, expression of three genes (VEGFA, CXCL8, IDH1) was statistically significant and were associated with a worse prognosis among patients with GBM. This evidence concerns the gene IDH1 and glioblastoma.